MedTrace Logo

Cholesterol and CYP3A4/5 Metabolism Across Pregnancy and Postpartum

NCT05504889 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2024-04-24

No results posted yet for this study

Summary

This study addresses the second aim of the grant (R01 HD0899455), which is to determine temporal changes in CYP3A4-mediated drug metabolism sequentially across pregnancy and after birth.

Conditions

  • Pregnancy Related

Sponsors & Collaborators

Principal Investigators

  • Katherine L Wisner, M.D., M.S. · Northwestern University

  • Hyunyoung Jeong, PharmD, PhD · Purdue University

  • Catherine S Stika, M.D. · Northwestern University

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-17
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05504889 on ClinicalTrials.gov